I can speak from my perspective of research. What we're interested in—one of the topics—is the intersection of the microbe and the host. That's a very interesting paradigm that parallels, perhaps, some aspect of sepsis.
When we think of human infections and syndromes, these syndromes are often complicated to diagnose. First is understanding the basic science of where sepsis comes from or, for example in my case, something as simple as pneumonia. You would think that pneumonia is very straightforward, but as a clinical syndrome, it is very ambiguous. It actually leads to the overuse, most certainly, of antibiotics, because somebody who has a cough, an abnormal chest X-ray and a few other relatively non-specific symptoms is assumed to have a bacterial infection that we're going to treat with antibiotics.
The basic science is important to understand: What is a disease and how would we properly diagnose it? From there, the molecular level or the epidemiological level is about understanding what molecules are important in order to design the right diagnostic tools, to which we'll apply either the proper stewardship or the proper therapy.
